Bidding hard price reduction into a disaster of low-cost drugs!

Source: special contribution of saberland: the drug price of jiangbianniao 2015-4-9 is the focus of social attention The current drug price does not exclude the false high, nor can we deny the false low What is the false high price of drugs? The price is too much higher than the cost What is the false low price of medicine, that is, the price is close to or even lower than the cost The false high price of drugs harms patients and medical insurance funds, which is not desirable; but the false low price of drugs harms pharmaceutical enterprises, harms drug R & D and innovation, even endangers the sustainability of drug reproduction, leading to the disappearance of low-cost drugs, the dominance of high-cost drugs, and harms patients and medical insurance funds, which is also not desirable It's hard to confirm whether the price is normal or high or low Because it involves not only production cost and sales volume, but also R & D fund calculation, fixed cost allocation and gray black promotion expense payment It is difficult for non enterprise professional financial personnel to figure it out But there are also socially accepted views For example, drugs with inflated prices are often imported drugs, patented drugs, exclusive varieties of drugs, newly marketed drugs, and drugs that have not been bidding; drugs with inflated prices are often drugs that have not been adjusted for many years, drugs that have been bidding for many rounds of competition, and drugs with multiple trade names that can be replaced by each other It is self-evident that the patients feel very deep when the drug price is high What about the medicine with low price? One is to unreasonably "give up profits and not let the market" when bidding In order to win the bid and offer a bid price lower than the comprehensive cost and higher than the variable cost, it is impossible to maintain simple reproduction and cut off the supply after winning the bid The other is to eliminate low-cost drugs from the market, or to improve the price and enter the market again In fact, the industry has a basic idea about the price of a drug, but the evidence is insufficient, the calculation is difficult, and it cannot and will not be open to the public Therefore, the right way to deal with this problem is: withdraw from the bidding for the drugs suspected to be falsely high and falsely low, and determine the price through negotiation; for the drugs with roughly normal price, price through bidding The existing competitive varieties can play a role of price reduction only by the bidding mechanism For the drug with high price, the price is reduced by increasing the purchase volume through price negotiation The price is exchanged by quantity, the price is protected by quantity, the profit rate is reduced, and the total profit is guaranteed, so as to make the patient and the enterprise win-win For the drugs with low price, the way of price negotiation is adopted to ensure the supply by properly raising the price, to maintain the ability of sustainable supply, so that low-cost drugs can also occupy a place in the market and not be forced to disappear It is a new measure adopted by a few provinces in this round of drug bidding It has little effect on drugs with real high prices For drugs with normal prices and low profits, it has no small killing power and even brings disaster to some drugs Therefore, this is not a scientific management method, but a typical lazy and foolish government No matter how to use the form of bidding or negotiation, the principle of linking quantity and price is a must From the simplest economic principle, we can know that if the sales volume (purchase volume) is large, the cost will be low and the price will be low Sales volume is the most important factor to determine the price besides production cost Therefore, to determine the bidding price or to bargain, we should first determine the sales volume, that is, the purchase volume This is self-evident common sense However, in the current drug bidding, if the bidding is not linked to the procurement or the purchase quantity is not determined in advance, what's the reason for the enterprises to force them to bid blindly by using administrative force beyond their authority? What's the reason for the enterprises to determine the bidding price for such bidding? This kind of practice even does not recognize the basic logical relationship of things! It's extremely inappropriate In the absence of the guarantee of purchase quantity, the only way to reduce the price is to determine the bid price After that, the hospital will negotiate the bid price again and further reduce the price! In the end, here, the volume price linkage provides a grand reason for another price reduction without reason, principle and bottom line There is no minimum and only lower price after the only low price is the lowest price to achieve bidding We should regard the volume price linkage as a necessary part of normal commodity trading and not as a new tool to reduce the price Therefore, whether bidding or price negotiation, we should determine the purchase quantity in advance, and we should never follow our own will, follow the interests, hang up if you want, or hang up if you want This is to make people laugh! Author: Zhejiang Pharmaceutical Industry Association